S. Lankiewicz, S Zimmermann, C Hollmann, T Hillemann, T. F. Greten, (2008) Circulating tumour cells as a predictive factor for response to systemic chemotherapy in patients with advanced colorectal cancer, Mol Oncol, 2(4), 349-355.
 C. Wu, H. Hao, L. Li, X. Zhou, Z. Guo, L. Zhang, X. Zhang, W. Zhong, H. Guo, R.M. Bremner, P. Lin, (2009) Pre-liminary investigation of the clinical significance of de-tecting circulating tumor cells enriched from lung cancer patients, J Thorac Oncol, 4(1), 30-36.
 T. Okegawa, K. Nutahara, E. Higashihara, (2008) Im-munomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsive-ness in patients with hormone naive metastatic prostate cancer, J Urol, 180(4), 1342-1347.
 M. Tewes, B. Aktas, A. Welt, S. Mueller, S. Hauch, R. Kimmig, S. Kasimir-Bauer, (2009) Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies, Breast Cancer Res Treat, 115(3), 581-590.
 S. Maheswaran, L.V. Sequist, S. Nagrath, L. Ulkus, B. Brannigan, C.V. Collura, E. Inserra, S. Diederichs, A. J. Iafrate, D. W. Bell, S. Digumarthy, A. Muzikansky, D. Irimia, J. Settleman, R. G. Tompkins, T. J. Lynch, M. Toner, D. A. Haber, (2008) Detection of mutations in EGFR in circulating lung-cancer cells, N Engl J Med, 359(4), 366- 377.
 M. Ignatiadis, G. Kallergi, M. Ntoulia, M. Perraki, S. Apostolaki, M. Kafousi, G. Chlouverakis, E. Stathopoulos, E. Lianidou, V. Georgoulias, D. Mavroudis, (2008) Prog-nostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer, Clin Cancer Res, 14(9), 2593-2600.
 N. Xenidis, M. Ignatiadis, S. Apostolaki, M. Perraki, K. Kalbakis, S. Agelaki, E. N. Stathopoulos, G. Chlouverakis, E. Lianidou, S. Kakolyris, V. Georgoulias, D. Mavroudis, (2009) Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer, J Clin Oncol, 27(13), 2177-2184.
 S. J. Cohen, C. J. Punt, N. Iannotti, B. H. Saidman, K. D. Sabbath, N. Y. Gabrail, J. Picus, M. A. Morse, E. Mitchell, M. C. Miller, G. V. Doyle, H. Tissing, L. W. Terstappen, N. J. Meropol, (2009) Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer, Ann Oncol, 20(7), 1223-1229.
 M. J. Serrano, P. Sánchez-Rovira, M. Delgado-Rodriguez, J. J. Gaforio, (2009) Detection of circulating tumor cells in the context of treatment: prognostic value in breast cancer, Cancer Biol Ther, 8(8), 671-675.
 H. I. Scher, X. Jia, J. S. de Bono, M. Fleisher, K. J. Pienta, D. Raghavan, G. Heller, (2009) Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data, Lancet Oncol, 10(3), 233-239.
 T. Kuroda, N. Morikawa, K. Matsuoka, A. Fujino, T. Honna, A. Nakagawa, M. Kumagai, H. Masaki, M. Saeki, (2008) Prognostic significance of circulating tumor cells and bone marrow micrometastasis in advanced neuro-blastoma, J Pediatr Surg, 43(12), 2182-2185.
 J. S. de Bono, H. I. Scher, R. B. Montgomery, C. Parker, M. C. Miller, H. Tissing, G. V. Doyle, L. W. Terstappen, K. J. Pienta, D. Raghavan, (2008) Circulating tumor cells predict survival benefit from treatment in metastatic castration -resistant prostate cancer, Clin Cancer Res, 14(19), 6302- 6309.
 B. J. Curry, K. Myers, P. Hersey, (1998) Polymerase chain reaction detection of melanoma cells in the circulation: relation to clinical stage, surgical treatment, and recur-rence from melanoma, J Clin Oncol, 16(5), 1760-1769.
 F. S. Celi, M. M. Cohen, S. E. Antonarakis, E. Wertheimer, J. Roth, A. R. Shuldiner, (1994) Determination of gene dosage by a quantitative adaptation of the polymerase chain reaction (gd-PCR): rapid detection of deletions and duplications of gene sequences.Genomics, 21(2), 304- 310.
 C. Y. Young, B. T. Montgomery, P. E. Andrews, S. D. Qui, D. L. Bilhartz, D. J. Tindall, (1991) Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP, Cancer Res, 51(14), 3748-3752.
 S. D. Qiu, C. Y. Young, D. L. Bilhartz, J. L. Prescott, G. M. Farrow, W. W. He, D. J. Tindall, (1990) In situ hybridiza-tion of prostate-specific antigen mRNA in human prostate, J Urol, 144(6), 1550-1556.
 S. Hosch, J. Kraus, P. Scheunemann, J. R. Izbicki, C. Schneider, U. Schumacher, K. Witter, M. R. Speicher, K. Pantel, (2000) Malignant potential and cytogenetic char-acteristics of occult disseminated tumor cells in eso-phageal cancer, Cancer Res, 60(24), 6836-6840.
 I. H. Wong, W. Y. Lau, T. Leung, W. Yeo, P. J. Johnson, (1999) Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carci-noma: a quantitative analysis, Clin Cancer Res, 5(12), 4021-4027.
 K. Peck, Y. P. Sher, J. Y. Shih, S. R. Roffler, C. W. Wu, P. C. Yang, (1998) Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients, Cancer Res, 58(13), 2761-2765.